160 results
Page 3 of 8
8-K
EX-99.1
jry1cx89u8wli
16 Aug 21
FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer
5:23pm
8-K
EX-99.1
re7ii
11 Aug 21
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
8:30am
8-K
EX-99.1
e25 2hsje
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
buq5amm
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
8-K
EX-99.1
6uk42t2
17 Jun 21
FibroGen and HiFiBiO Announce Transformative Partnership to
4:16pm
8-K
s1r lpjpbj2e53b
14 May 21
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
wa4i 5n5ezz8t0qefb
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
ed505ilqb xigjp3mv
7 Apr 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
4ajly13rfk1v81ftwf
6 Apr 21
Company Continues to be Confident in the Benefit / Risk Profile of Roxadustat
4:59pm
8-K
j8e320k odol23vstvax
6 Apr 21
Company Continues to be Confident in the Benefit / Risk Profile of Roxadustat
4:59pm
8-K
EX-99.1
l3tovi9173fbi2o5
1 Mar 21
FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm